Skip to search formSkip to main contentSkip to account menu

erythromycin lactobionate

Known as: erythromycin lactobionate [Chemical/Ingredient] 
The lactobionate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin lactobionate… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Review
1994
Review
1994
We describe two patients who develop torsades de pointes in a temporal relationship to the intravenous administration of… 
1990
1990
Fatal fulminant hepatic failure accompanied by brisk hemolysis developed in an elderly man after intravenous administration of… 
1986
1986
Ten healthy normal volunteers received an intravenous infusion of erythromycin lactobionate over 60 min to a total dose of 800 mg… 
1986
1986
Two cases of severe hearing loss due to intravenous administration of erythromycin lactobionate are described. Documented… 
1983
1983
1 Sixteen patients with bronchopulmonary infection received 500 mg erythromycin lactobionate by intravenous infusion every 8 h… 
1977
1977
Three patients are presented who developed reversible sensorineural hearing losses during treatment with intravenous erythromycin… 
1973
1973
To the Editor.— Erythromycin may cause adverse reactions of two types: (1) allergic such as fever, eosinophilia, skin eruptions…